Lenmeldy

atidarsagene autotemcel

Approval

ApplicationBLA 125758
Approval dateMar 18, 2024
Approval year2024
SponsorOrchard Therapeutics (Europe) Limited

FDA-approved use

the treatment of children with pre-symptomatic late infantile (PSLI), pre-symptomatic early juvenile (PSEJ) or early symptomatic early juvenile (ESEJ) metachromatic leukodystrophy (MLD)

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Lenmeldy: